Skip to main content
    • Aa
    • Aa

Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive–compulsive disorder

  • M. J. Maher (a1), J. D. Huppert (a2) (a3), H. Chen (a1) (a4), N. Duan (a1) (a4), E. B. Foa (a2), M. R. Liebowitz (a1) (a4) and H. B. Simpson (a1) (a4)...

Cognitive-behavioral therapy (CBT) consisting of exposure and response prevention (EX/RP) is efficacious as a treatment for obsessive–compulsive disorder (OCD). However, about half of patients have a partial or poor response to EX/RP treatment. This study examined potential predictors and moderators of CBT augmentation of pharmacotherapy, to identify variables associated with a poorer response to OCD treatment.


Data were drawn from a large randomized controlled trial that compared the augmenting effects of EX/RP to stress management training (SMT; an active CBT control) among 108 participants receiving a therapeutic dose of a serotonin reuptake inhibitor (SRI). Stepwise regression was used to determine the model specification.


Pretreatment OCD severity and gender were significant moderators of outcome: severity affected SMT (but not EX/RP) outcome; and gender affected EX/RP (but not SMT) outcome. Adjusting for treatment type and pretreatment severity, significant predictors included greater co-morbidity, number of past SRI trials, and lower quality of life (QoL). Significant moderators, including their main-effects, and predictors accounted for 37.2% of the total variance in outcome, comparable to the impact of treatment type alone (R2=30.5%). These findings were replicated in the subgroup analysis of EX/RP alone (R2=55.2%).


This is the first randomized controlled study to examine moderators and predictors of CBT augmentation of SRI pharmacotherapy. Although effect sizes for individual predictors tended to be small, their combined effect was comparable to that of treatment. Thus, future research should examine whether monitoring for a combination of these risk factors and targeting them with multi-modular strategies can improve EX/RP outcome.

Corresponding author
*Address for correspondence: H. B. Simpson, M.D., Ph.D., Associate Professor of Clinical Psychiatry, Columbia University, 1051 Riverside Drive, Unit 69, New York, NY10032, USA. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

J Abramowitz , E Foa (2000). Does comorbid major depressive disorder influence outcome of exposure and response prevention for OCD? Behavior Therapy 31, 795800.

JS Abramowitz , ME Franklin , SA Schwartz , JM Furr (2003). Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology 71, 10491057.

LR Baxter Jr., JM Schwartz , KS Bergman , MP Szuba , BH Guze , JC Mazziotta , A Alazraki , CE Selin , HK Ferng , P Munford , ME Phelps (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry 49, 681689.

DW Black , P Monahan , J Gable , N Blum , G Clancy , P Baker (1998). Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. Journal of Clinical Psychiatry 59, 420425.

C Blanco , M Olfson , DJ Stein , HB Simpson , MJ Gameroff , WH Narrow (2006). Treatment of obsessive-compulsive disorder by U.S. psychiatrists. Journal of Clinical Psychiatry 67, 946951.

AW Buchanan , KS Meng , IM Marks (1996). What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder? Anxiety 2, 2227.

J Cottraux , I Note , SN Yao , S Lafont , B Note , E Mollard , M Bouvard , A Sauteraud , M Bourgeois , J-F Dartigues (2001). A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychotherapy and Psychosomatics 70, 288297.

E de Haan , P van Oppen , AJ van Balkom , P Spinhoven , KA Hoogduin , R Van Dyck (1997). Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy. Acta Psychiatrica Scandinavica 96, 354361.

D Denys , H Burger , H van Megen , F de Geus , H Westenberg (2003). A score for predicting response to pharmacotherapy in obsessive-compulsive disorder. International Clinical Psychopharmacology 18, 315322.

E Foa , J Abramowitz , M Franklin , MJ Kozak (1999). Feared consequences, fixity of belief, and treatment outcome in patients with obsessive-compulsive disorder. Behavior Therapy 30, 717724.

EB Foa , JB Grayson , GS Steketee , HG Doppelt , RM Turner , PR Latimer (1983 a). Success and failure in the behavioral treatment of obsessive-compulsives. Journal of Consulting and Clinical Psychology 51, 287297.

EB Foa , MR Liebowitz , MJ Kozak , S Davies , R Campeas , ME Franklin , JD Huppert , K Kjernisted , V Rowan , AB Schmidt , HB Simpson , X Tu (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 162, 151161.

BS Gershuny , L Baer , MA Jenike , WE Minichiello , S Wilhelm (2002). Comorbid posttraumatic stress disorder: impact on treatment outcome for obsessive-compulsive disorder. American Journal of Psychiatry 159, 852854.

WK Goodman , LH Price , SA Rasmussen , C Mazure , RL Fleischmann , CL Hill , GR Heninger , DS Charney (1989). The Yale–Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry 46, 10061011.

M Hamilton (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology 32, 5055.

M Hamilton (1960). A Rating Scale for Depression. Journal of Neurology, Neurosurgery, and Psychiatry 23, 5662.

CA Hoogduin , HJ Duivenvoorden (1988). A decision model in the treatment of obsessive-compulsive neuroses. British Journal of Psychiatry 152, 516521.

JD Huppert , HB Simpson , K Nissenson , M Liebowitz , EB Foa (2009). Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls. Depression and Anxiety 26, 3945.

D Jacobson , A Wu , J Feinberg (2003). Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease. Journal of Clinical Epidemiology 56, 874879.

GP Keijsers , CA Hoogduin , CP Schaap (1994). Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. British Journal of Psychiatry 165, 781786.

PT Lelliott , HF Noshirvani , M Basoglu , IM Marks , WO Monteiro (1988). Obsessive-compulsive beliefs and treatment outcome. Psychological Medicine 18, 697702.

D Mataix-Cols , IM Marks , JH Greist , KA Kobak , L Baer (2002). Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychotherapy and Psychosomatics 71, 255262.

S Saxena , KM Maidment , T Vapnik , G Golden , T Rishwain , RM Rosen , G Tarlow , A Bystritsky (2002). Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. Journal of Clinical Psychiatry 63, 2127.

HB Simpson , EB Foa , MR Liebowitz , D Roth Ledley , JD Huppert , SP Cahill , D Vermes , AB Schmidt , EA Hembree , M Franklin , R Campeas , C Hahn , E Petkova (2008). A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. American Journal of Psychiatry 165, 621630.

HB Simpson , JD Huppert , E Petkova , EB Foa , MR Liebowitz (2006). Response versus remission in obsessive-compulsive disorder. Journal of Clinical Psychiatry 67, 269276.

G Steketee , DL Chambless , GQ Tran (2001). Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Comprehensive Psychiatry 42, 7686.

G Steketee , LJ Shapiro (1995). Predicting behavioral treatment outcome for agoraphobia and obsessive compulsive disorder. Clinical Psychology Review 15, 317346.

SE Stewart , C-H Yen , DE Stack , MA Jenike (2006). Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment. Journal of Psychiatric Research 40, 511519.

EA Storch , LJ Merlo , MJ Larson , GR Geffken , HD Lehmkuhl , ML Jacob , TK Murphy , WK Goodman (2008). Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 47, 583592.

NH Tenneij , HJ van Megen , DA Denys , HG Westenberg (2005). Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. Journal of Clinical Psychiatry 66, 11691175.

DF Tolin , N Maltby , GJ Diefenbach , SE Hannan , P Worhunsky (2004). Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial. Journal of Clinical Psychiatry 65, 922931.

MM Weissman , S Bothwell (1976). Assessment of social adjustment by patient self-report. Archives of General Psychiatry 33, 11111115.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *